Details of the Drug Reposition

General Information of This Drug (ID: DM2XSG0)

Drug Name
GMA105   DM2XSG0
Drug Type
Antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Type-2 diabetes DIS3X247 5A11 Phase 3 [1]
Obesity DIS47Y1K 5B81 Phase 3 [1]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of Gmax Biopharm.